Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1235-1240 (27 May), doi:10.1136/bmj.38828.593125.55 (published 17 May 2006)
J Trinder, specialist registrar in obstetrics and gynaecology1, P Brocklehurst, director2, R Porter, consultant obstetrician and gynaecologist3, M Read, consultant obstetrician and gynaecologist4, S Vyas, consultant obstetrician and gynaecologist1, L Smith, general practitioner5
1 Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, 2 National Perinatal Epidemiology Unit, University of Oxford, Oxford OX3 7LF, 3 Royal United Hospital, Bath BA1 3NG, 4 Gloucestershire Royal NHS Hospital, Gloucester GL1 3NN, 5 East Somerset Research Consortium, West Coker, Somerset BA22 9AH
Correspondence to: J Trinder, Consultant in Maternal Medicine and Obstetrics, Department of Obstetrics and Gynaecology, St Michael's Hospital, Southwell St, Bristol BS2 8EG jo.trinder{at}bristol.ac.uk
Objective To ascertain whether a clinically important difference exists in the incidence of gynaecological infection between surgical management and expectant or medical management of miscarriage.
Design Randomised controlled trial comparing medical and expectant management with surgical management of first trimester miscarriage.
Setting Early pregnancy assessment units of seven hospitals in the United Kingdom.
Participants Women of less than 13 weeks' gestation, with a diagnosis of early fetal demise or incomplete miscarriage.
Interventions Expectant management (no specific intervention); medical management (vaginal dose of misoprostol preceded, for women with early fetal demise, by oral mifepristone 24-48 hours earlier); surgical management (surgical evacuation).
Main outcome measures Confirmed gynaecological infection at 14 days and eight weeks; need for unplanned admission or surgical intervention.
Results 1200 women were recruited: 399 to expectant management, 398 to medical management, and 403 to surgical management. No differences were found in the incidence of confirmed infection within 14 days between the expectant group (3%) and the surgical group (3%) (risk difference 0.2%, 95% confidence interval - 2.2% to 2.7%) or between the medical group (2%) and the surgical group (0.7%, - 1.6% to 3.1%). Compared with the surgical group, the number of unplanned hospital admissions was significantly higher in both the expectant group (risk difference - 41%, - 47% to - 36%) and the medical group (- 10%, - 15% to - 6%). Similarly, when compared with the surgical group, the number of women who had an unplanned surgical curettage was significantly higher in the expectant group (risk difference - 39%, - 44% to - 34%) and the medical group (- 30%, - 35% to - 25%).
Conclusions The incidence of gynaecological infection after surgical, expectant, and medical management of first trimester miscarriage is low (2-3%), and no evidence exists of a difference by the method of management. However, significantly more unplanned admissions and unplanned surgical curettage occurred after expectant management and medical management than after surgical management.
Trial registration National Research Register: N0467011677/N0467073587.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses